U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock
80.59 USD
+0.17 (+0.21%)
80.59 USD
0 (0%)
Overall USPH gets a fundamental rating of 5 out of 10. We evaluated USPH against 100 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. USPH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
In the past year USPH had a positive cash flow from operations.
USPH had positive earnings in each of the past 5 years.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
USPH's Return On Assets of 3.01% is fine compared to the rest of the industry. USPH outperforms 64.00% of its industry peers.
Looking at the Return On Equity, with a value of 7.15%, USPH is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
USPH's Return On Invested Capital of 6.11% is fine compared to the rest of the industry. USPH outperforms 63.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for USPH is below the industry average of 9.44%.
The 3 year average ROIC (5.78%) for USPH is below the current ROIC(6.11%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROIC | 6.11% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH's Profit Margin of 4.75% is fine compared to the rest of the industry. USPH outperforms 78.00% of its industry peers.
USPH's Profit Margin has declined in the last couple of years.
The Operating Margin of USPH (11.52%) is better than 81.00% of its industry peers.
USPH's Operating Margin has declined in the last couple of years.
USPH's Gross Margin of 18.80% is on the low side compared to the rest of the industry. USPH is outperformed by 63.00% of its industry peers.
USPH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USPH is destroying value.
The number of shares outstanding for USPH has been increased compared to 1 year ago.
Compared to 5 years ago, USPH has more shares outstanding
The debt/assets ratio for USPH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.24 indicates that USPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.24, USPH is in line with its industry, outperforming 50.00% of the companies in the same industry.
USPH has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as USPH would need 2.82 years to pay back of all of its debts.
USPH has a better Debt to FCF ratio (2.82) than 75.00% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that USPH is not too dependend on debt financing.
USPH has a Debt to Equity ratio of 0.30. This is in the better half of the industry: USPH outperforms 67.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 2.24 |
ROIC/WACC0.72
WACC8.54%
2.3 Liquidity
USPH has a Current Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH's Current ratio of 1.20 is in line compared to the rest of the industry. USPH outperforms 44.00% of its industry peers.
A Quick Ratio of 1.20 indicates that USPH should not have too much problems paying its short term obligations.
USPH has a Quick ratio (1.20) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.17% over the past year.
USPH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
The Revenue has grown by 17.50% in the past year. This is quite good.
Measured over the past years, USPH shows a small growth in Revenue. The Revenue has been growing by 6.85% on average per year.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
3.2 Future
Based on estimates for the next years, USPH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 9.56% on average per year.
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 31.00, the valuation of USPH can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of USPH is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.54. USPH is around the same levels.
With a Price/Forward Earnings ratio of 26.45, USPH can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as USPH.
When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (23.78), we can say USPH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31 | ||
| Fwd PE | 26.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 65.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, USPH is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.53 | ||
| EV/EBITDA | 12.2 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USPH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.06
PEG (5Y)N/A
EPS Next 2Y8.66%
EPS Next 3Y8.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.36%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.44. USPH pays more dividend than 94.00% of the companies in the same industry.
USPH's Dividend Yield is comparable with the S&P500 average which is at 2.27.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
5.2 History
The dividend of USPH is nicely growing with an annual growth rate of 9.09%!
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 75.41% of its income as dividend. This is not a sustainable payout ratio.
USPH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP75.41%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
80.59
+0.17 (+0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.19%
Inst Owner Change5.17%
Ins Owners1.87%
Ins Owner Change-1.14%
Market Cap1.22B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target107.27 (33.11%)
Short Float %5.73%
Short Ratio4.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)-0.97%
PT rev (3m)-0.97%
EPS NQ rev (1m)-2.44%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)-5.06%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31 | ||
| Fwd PE | 26.45 | ||
| P/S | 1.61 | ||
| P/FCF | 21.53 | ||
| P/OCF | 17.62 | ||
| P/B | 2.43 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.2 |
EPS(TTM)2.6
EY3.23%
EPS(NY)3.05
Fwd EY3.78%
FCF(TTM)3.74
FCFY4.65%
OCF(TTM)4.57
OCFY5.68%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)8.06
PEG (5Y)N/A
Graham Number44.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.01% | ||
| ROE | 7.15% | ||
| ROCE | 8.08% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.29% | ||
| ROICexgc | 36.03% | ||
| OM | 11.52% | ||
| PM (TTM) | 4.75% | ||
| GM | 18.8% | ||
| FCFM | 7.5% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 1.37 | ||
| Cap/Depr | 53.9% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | 9.84 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 157.98% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 2.24 |
F-Score6
WACC8.54%
ROIC/WACC0.72
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y3.85%
EPS Next 2Y8.66%
EPS Next 3Y8.49%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.97%
Revenue Next 2Y11.52%
Revenue Next 3Y9.56%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.26%
EBIT Next 3Y18.34%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?
ChartMill assigns a fundamental rating of 5 / 10 to USPH.
Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?
ChartMill assigns a valuation rating of 3 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.
What is the profitability of USPH stock?
U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for USPH stock?
The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 3.85% in the next year.
Can you provide the dividend sustainability for USPH stock?
The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.